Delivery Order SPE2DB22D1106-SPE2DB24FDVT8
- Not listed
- This federal contract award, with ID SPE2DB22D2006|SPE2DB24FV7SB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,215.17 firm fixed-price delivery order is for the supply of Doxepin HCL 3 mg tablets. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,020.70, is for the delivery of doxepin HCL 6 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, with ID SPE2DX15D6038|SPE2DX24F1ZQ4, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,135.14 delivery order is for Doxepin HCl 3 mg tablets, with a completion date of November 17, 2023. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6CVR, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $20,230.07 firm fixed-price delivery order is for the supply of 3 mg Doxepin HCL tablets, with an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $9,285.16 fixed-price delivery order covers the provision of 3 mg doxepin hydrochloride tablets to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,180.70, is for the delivery of 4,562,253,135 tablets of Doxepin Hydrochloride 3 mg. The contract has a completion date of September 21, 2023 and is a firm fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc.,...
- This federal contract award is for the delivery of Doxepin HCL 3 mg tablets to the Defense Logistics Agency (DLA). The $49,314.15 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of November 7, 2023 and was not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,834.02 firm fixed-price delivery order contract is for the supply of DOXEPIN HCL 3 MG TABLET 30S, with a performance period through February 14, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Doxepin HCL 6 mg tablets. The contract has a ceiling value of $1,874.43 and is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.68 delivery order contract is for the supply of Doxepin HCL 3 mg tablets, with a completion date of December 21, 2023. The contract is not designated as a set-aside and is a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDVT8Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,209.72 firm fixed-price delivery order (SPE2DB22D1106|SPE2DB24FDVT8) is for the provision of Doxepin HCL 3 mg tablets. The award has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 1/18/24 |